KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fulgent Genetics (FLGT) Receivables - Net (2016 - 2025)

Historic Receivables - Net for Fulgent Genetics (FLGT) over the last 11 years, with Q3 2025 value amounting to $71.2 million.

  • Fulgent Genetics' Receivables - Net rose 2420.31% to $71.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $71.2 million, marking a year-over-year increase of 2420.31%. This contributed to the annual value of $69.0 million for FY2024, which is 3498.59% up from last year.
  • As of Q3 2025, Fulgent Genetics' Receivables - Net stood at $71.2 million, which was up 2420.31% from $77.2 million recorded in Q2 2025.
  • Over the past 5 years, Fulgent Genetics' Receivables - Net peaked at $216.5 million during Q1 2021, and registered a low of $34.8 million during Q2 2023.
  • Its 5-year average for Receivables - Net is $89.9 million, with a median of $71.2 million in 2025.
  • In the last 5 years, Fulgent Genetics' Receivables - Net soared by 329835.19% in 2021 and then crashed by 7388.73% in 2023.
  • Quarter analysis of 5 years shows Fulgent Genetics' Receivables - Net stood at $138.9 million in 2021, then tumbled by 62.03% to $52.7 million in 2022, then decreased by 3.07% to $51.1 million in 2023, then skyrocketed by 34.99% to $69.0 million in 2024, then increased by 3.14% to $71.2 million in 2025.
  • Its last three reported values are $71.2 million in Q3 2025, $77.2 million for Q2 2025, and $71.5 million during Q1 2025.